Screener / SEC EDGAR /CIK 0001818331 /10-K filed Feb 23, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Health Services

GeneDx Holdings Corp. WGS

Compare with peers Embed
Cash returned and share count

No buyback or stock pay figures in its 10-K data yet

XBRL, 10-K

Cash runway

Cash on the balance sheet of Sep 30, 2026 against the operating cash it used over the last four quarters · XBRL

Cash and short-term investments $170.1M cash $96.1M + short-term investments $74.0M
Operating cash used $75.1M $6.3M a month on average, over the last four quarters
Months of cash at that pace 27 months cash divided by the monthly operating cash used · at the newest quarter's pace: 48 months
Operating cash flowFY2022FY2023FY2024FY2025
Cash from operations-$319.2M-$180.1M-$28.5M$33.3M

Shown only when operating cash flow of the last twelve months is negative. A fact about the past twelve months, not a forecast: the company can raise money, cut costs or change pace. Debt due is on the Debt tab; share sales are in the dilution card below.

New shares against shares bought back

Dilution: new shares, stock pay and buybacks · S-3 and 424B, 3 years; 10-K

Shares offered

Since Nov 17, 2023: 2 at-the-market programs, 1 shelf registration. Latest at-the-market program for common stock: Apr 30, 2024, up to $75.0M.

“Units From time to time, we may offer shares of our Class A common stock (the “Class A common stock”) or preferred stock, debt securities, warrants to purchase our Class A common stock, preferred stock or debt securities, subscription rights to purchase our Class A common stock, preferred stock or debt securities and/or units consisting of some or all of these securities, in any combination, together or separately, …”

S-3ASR, Oct 28, 2025
Every offering filing

Paid in stock and bought back

No stock pay or buyback lines in the 10-K XBRL.

Where the cash came from and where it went

FY2025, from the cash flow statement in the 10-K, added up

Operating cash flowShares soldOther, netCapital spendingAdded to cash Operating cash flow: $33.3M Operating cash flow $33.3M Shares sold: $2.0M Shares sold $2.0M Other, net: $3.5M Other, net $3.5M Capital spending: $19.0M Capital spending $19.0M Added to cash: $19.8M Added to cash $19.8M

Came from

Operating cash flow $33.3M
Shares sold $2.0M
Other, net
investments bought and sold, other financing and investing lines, and exchange rates
$3.5M

Each number is a line of the cash flow statement as the company tagged it. "Other, net" is what those lines do not cover (investments bought and sold, other financing and investing lines, and exchange rates); Tickdelta does not estimate it.

Where the operating cash went, year by year

FY2019 to FY2025 · cash flow statements, 10-K XBRL

7 years
Operating cash, added up -$796.8M 7 fiscal years, FY2019 to FY2025
Reinvested - not shown: operating cash was negative in a year of the span
Returned to owners - not shown: operating cash was negative in a year of the span
Debt repaid - gross repayments added up; debt that was refinanced counts each time
Fiscal yearOperating cashCapital spendingAcquisitions
Dec 31, 2025 $33.3M $19.0M-
Dec 31, 2024 -$28.5M $5.5M-
Dec 31, 2023 -$180.1M $5.2M$12.1M
Dec 31, 2022 -$319.2M $7.2M$127.0M
Dec 31, 2021 -$190.4M $9.4M-
Dec 31, 2020 -$93.1M $24.1M-
Dec 31, 2019 -$18.7M $11.9M-
Added up-$796.8M $82.3M$139.1M

Each bar is one fiscal year; its colours add up to what the cash flow statement says the company spent on each line, and the line across it is that year's operating cash flow. Spending above the line was paid from new debt, shares sold or cash on hand. A bar part links to the 10-K it comes from. A line the company did not report is left out, not estimated, so the shares are of operating cash only and can add up to more or less than 100%. Debt repaid is the gross amount, so refinanced debt is counted each time it is repaid. A reading aid, not a grade: Tickdelta does not say whether a split was good. Banks and insurers are left out.

Buybacks, dividends and share count

Year by year · XBRL, each 10-K

No buyback or share count data in the 10-K XBRL.

What the 10-Ks show for each CEO's years

Each CEO's years · the CEO of each fiscal year as named in the proxy's pay versus performance table

Katherine Stueland

FY2025 · 1 year in the table
Operating cash flow
$33.3M
Capital spending
$19.0M
Stock-based pay
$32.2M
Diluted shares since FY2024
+6.5%
Revenue since FY2024
+40%
Debt since FY2024
-$1.2M
CEO pay (reported)
$13.5M
The proxy that names the CEO

Sources

The cash flow statement, dividends per share and diluted share count in each 10-K's XBRL; Part II Item 2 of each 10-Q for monthly buybacks; offering prospectuses (S-3, 424B) for new shares; Form D data sets for private raises.

Also

CEO pay: what the CEO was paid over the same years.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/WGS/export.csv") into a cell.

Next:CEO pay
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.